Taclonex®

DRUG2 trials

Sponsors

Glenmark Pharmaceuticals Ltd. India, Sun Pharmaceutical Industries, Inc.

Conditions

Scalp Psoriasis

Phase 1

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis

CompletedNCT03880357

Sun Pharmaceutical Industries, Inc.Scalp Psoriasis

Start: 2018-10-22End: 2019-03-15Updated: 2019-03-19

Phase 3

To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp Psoriasis

CompletedNCT03331523

Glenmark Pharmaceuticals Ltd. IndiaScalp Psoriasis

Start: 2017-10-20End: 2018-10-25Updated: 2018-12-21